Imatinib
Showing 1 - 4 of 4
Flumatinib, Chronic Myeloid Leukemia, Chronic Phase, Imatinib Trial in Shenzhen (Flumatinib)
Recruiting
- Flumatinib
- +2 more
-
Shenzhen, Guangdong, ChinaThe Second People's Hospital of Shenzhen
Mar 15, 2022
CML, Imatinib Trial in Seoul (high-dose imatinib)
Completed
- CML
- Imatinib
- high-dose imatinib
-
Seoul, Korea, Republic ofNovartis Investigational Site
Mar 9, 2021
Prostatic Tumor, Genital Tumors, Male, Tumors, Abdominal Trial in Germany (STI571 (Glivec®))
Completed
- Prostatic Neoplasm
- +7 more
- STI571 (Glivec®)
-
Aachen, Germany
- +12 more
May 31, 2017
Chronic Myeloid Leukemia, Imatinib, Complete Molecular Response Trial in Seoul (Imatinib treatment discontinuing)
Unknown status
- Chronic Myeloid Leukemia
- +2 more
- Imatinib treatment discontinuing
-
Seoul, Korea, Republic of
- +1 more
Jan 10, 2014